US Stock MarketDetailed Quotes

Intensity Therapeutics (INTS)

Watchlist
  • 3.670
  • -0.070-1.87%
Close Jun 11 16:00 ET
  • 3.750
  • +0.080+2.18%
Pre 06:39 ET
9.92MMarket Cap-0.92P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Intensity Therapeutics (INTS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-25.57%2.53M
-27.81%11.97M
-1.97%3.14M
-23.45%2.73M
-46.64%2.71M
-28.44%3.39M
99.36%16.59M
-4.45%3.2M
43.32%3.57M
315.15%5.07M
Selling and administrative expenses
10.46%1.33M
-14.81%5.19M
32.52%1.64M
-16.84%1.18M
-22.71%1.16M
-37.50%1.21M
72.35%6.09M
-20.31%1.24M
24.58%1.42M
316.02%1.51M
-General and administrative expense
10.46%1.33M
-14.81%5.19M
32.52%1.64M
-16.84%1.18M
-22.71%1.16M
-37.50%1.21M
72.35%6.09M
-20.31%1.24M
24.58%1.42M
316.02%1.51M
Research and development costs
-45.41%1.2M
-35.36%6.79M
-23.64%1.5M
-27.80%1.55M
-56.75%1.54M
-22.24%2.19M
119.31%10.5M
9.22%1.97M
59.10%2.15M
314.78%3.56M
Operating profit
25.57%-2.53M
27.81%-11.97M
1.97%-3.14M
23.45%-2.73M
46.64%-2.71M
28.44%-3.39M
-99.36%-16.59M
4.45%-3.2M
-43.32%-3.57M
-315.15%-5.07M
Net non-operating interest income expense
526.67%94K
-42.68%180K
214.29%88K
22.92%59K
-82.65%17K
-89.29%15K
1,552.63%314K
-84.09%28K
-67.57%48K
144.14%98K
Non-operating interest income
526.67%94K
-42.68%180K
214.29%88K
22.92%59K
-82.65%17K
-89.29%15K
-3.09%314K
-84.09%28K
-67.57%48K
--98K
Non-operating interest expense
----
----
----
----
----
----
--0
--0
--0
--0
Other net income (expense)
-106.25%-2K
6,100.00%186K
116.67%1K
-66.67%3K
151K
32K
100.13%3K
-250.00%-6K
-35.71%9K
Special income (charges)
----
----
----
----
----
----
--0
--0
--0
--0
Other non- operating income (expenses)
-106.25%-2K
6,100.00%186K
116.67%1K
-66.67%3K
--151K
--32K
-87.50%3K
-250.00%-6K
-35.71%9K
----
Income before tax
27.28%-2.43M
28.66%-11.61M
4.09%-3.05M
23.97%-2.67M
48.96%-2.54M
27.29%-3.35M
-54.37%-16.27M
-0.28%-3.18M
-50.84%-3.51M
-34.32%-4.97M
Income tax
Net income
27.28%-2.43M
28.66%-11.61M
4.09%-3.05M
23.97%-2.67M
48.96%-2.54M
27.29%-3.35M
-54.37%-16.27M
-0.28%-3.18M
-50.84%-3.51M
-34.32%-4.97M
Net income continuous Operations
27.28%-2.43M
28.66%-11.61M
4.09%-3.05M
23.97%-2.67M
48.96%-2.54M
27.29%-3.35M
-54.37%-16.27M
-0.28%-3.18M
-50.84%-3.51M
-34.32%-4.97M
Minority interest income
Net income attributable to the parent company
27.28%-2.43M
28.66%-11.61M
4.09%-3.05M
23.97%-2.67M
48.96%-2.54M
27.29%-3.35M
-54.37%-16.27M
-0.28%-3.18M
-50.84%-3.51M
-34.32%-4.97M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
27.28%-2.43M
28.66%-11.61M
4.09%-3.05M
23.97%-2.67M
48.96%-2.54M
27.29%-3.35M
-37.14%-16.27M
-0.28%-3.18M
-50.84%-3.51M
1.07%-4.97M
Basic earnings per share
82.58%-0.96
70.73%-8.56
77.99%-1.2086
76.00%-1.5
63.89%-3.25
35.18%-5.51
15.25%-29.24
5.09%-5.49
-47.06%-6.25
74.83%-9
Diluted earnings per share
82.58%-0.96
70.73%-8.56
77.99%-1.2086
76.00%-1.5
63.89%-3.25
35.18%-5.51
15.25%-29.24
5.09%-5.49
-47.06%-6.25
74.83%-9
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -25.57%2.53M-27.81%11.97M-1.97%3.14M-23.45%2.73M-46.64%2.71M-28.44%3.39M99.36%16.59M-4.45%3.2M43.32%3.57M315.15%5.07M
Selling and administrative expenses 10.46%1.33M-14.81%5.19M32.52%1.64M-16.84%1.18M-22.71%1.16M-37.50%1.21M72.35%6.09M-20.31%1.24M24.58%1.42M316.02%1.51M
-General and administrative expense 10.46%1.33M-14.81%5.19M32.52%1.64M-16.84%1.18M-22.71%1.16M-37.50%1.21M72.35%6.09M-20.31%1.24M24.58%1.42M316.02%1.51M
Research and development costs -45.41%1.2M-35.36%6.79M-23.64%1.5M-27.80%1.55M-56.75%1.54M-22.24%2.19M119.31%10.5M9.22%1.97M59.10%2.15M314.78%3.56M
Operating profit 25.57%-2.53M27.81%-11.97M1.97%-3.14M23.45%-2.73M46.64%-2.71M28.44%-3.39M-99.36%-16.59M4.45%-3.2M-43.32%-3.57M-315.15%-5.07M
Net non-operating interest income expense 526.67%94K-42.68%180K214.29%88K22.92%59K-82.65%17K-89.29%15K1,552.63%314K-84.09%28K-67.57%48K144.14%98K
Non-operating interest income 526.67%94K-42.68%180K214.29%88K22.92%59K-82.65%17K-89.29%15K-3.09%314K-84.09%28K-67.57%48K--98K
Non-operating interest expense --------------------------0--0--0--0
Other net income (expense) -106.25%-2K6,100.00%186K116.67%1K-66.67%3K151K32K100.13%3K-250.00%-6K-35.71%9K
Special income (charges) --------------------------0--0--0--0
Other non- operating income (expenses) -106.25%-2K6,100.00%186K116.67%1K-66.67%3K--151K--32K-87.50%3K-250.00%-6K-35.71%9K----
Income before tax 27.28%-2.43M28.66%-11.61M4.09%-3.05M23.97%-2.67M48.96%-2.54M27.29%-3.35M-54.37%-16.27M-0.28%-3.18M-50.84%-3.51M-34.32%-4.97M
Income tax
Net income 27.28%-2.43M28.66%-11.61M4.09%-3.05M23.97%-2.67M48.96%-2.54M27.29%-3.35M-54.37%-16.27M-0.28%-3.18M-50.84%-3.51M-34.32%-4.97M
Net income continuous Operations 27.28%-2.43M28.66%-11.61M4.09%-3.05M23.97%-2.67M48.96%-2.54M27.29%-3.35M-54.37%-16.27M-0.28%-3.18M-50.84%-3.51M-34.32%-4.97M
Minority interest income
Net income attributable to the parent company 27.28%-2.43M28.66%-11.61M4.09%-3.05M23.97%-2.67M48.96%-2.54M27.29%-3.35M-54.37%-16.27M-0.28%-3.18M-50.84%-3.51M-34.32%-4.97M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 27.28%-2.43M28.66%-11.61M4.09%-3.05M23.97%-2.67M48.96%-2.54M27.29%-3.35M-37.14%-16.27M-0.28%-3.18M-50.84%-3.51M1.07%-4.97M
Basic earnings per share 82.58%-0.9670.73%-8.5677.99%-1.208676.00%-1.563.89%-3.2535.18%-5.5115.25%-29.245.09%-5.49-47.06%-6.2574.83%-9
Diluted earnings per share 82.58%-0.9670.73%-8.5677.99%-1.208676.00%-1.563.89%-3.2535.18%-5.5115.25%-29.245.09%-5.49-47.06%-6.2574.83%-9
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +5.48%
Sample Name
Sample Code
 +1.20%
Sample Name
Sample Code
 -2.64%
4
ProShares Ultra Energy
DIG
-2.80%
5
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
-2.93%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +6.08%
Sample Name
Sample Code
 +3.63%
Sample Name
Sample Code
 +3.45%
4
Amer Sports
AS
+3.22%
5
NetEase
NTES
+2.95%
View More
Middle East conflict spreads to the stock market! How should investors respond?
A critical window for U.S.-Iran talks has opened! According to Bloomberg, the U.S. and Iran are 'close' to signing an agreement around the u Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -